Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-7-29
pubmed:abstractText
Surgical margin status after radical prostatectomy (RP) is a significant risk factor for tumour recurrence. It is an intriguing concept to find a fluorescence marker for photodynamic diagnosis (PDD) to make tumour margins visible during surgery.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1873-7560
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1281-8
pubmed:meshHeading
pubmed-meshheading:19328622-Adenocarcinoma, pubmed-meshheading:19328622-Aged, pubmed-meshheading:19328622-Aminolevulinic Acid, pubmed-meshheading:19328622-Biopsy, Needle, pubmed-meshheading:19328622-Disease-Free Survival, pubmed-meshheading:19328622-Humans, pubmed-meshheading:19328622-Immunohistochemistry, pubmed-meshheading:19328622-Laparoscopy, pubmed-meshheading:19328622-Laparotomy, pubmed-meshheading:19328622-Male, pubmed-meshheading:19328622-Microscopy, Fluorescence, pubmed-meshheading:19328622-Middle Aged, pubmed-meshheading:19328622-Neoplasm Recurrence, Local, pubmed-meshheading:19328622-Photosensitizing Agents, pubmed-meshheading:19328622-Prognosis, pubmed-meshheading:19328622-Prospective Studies, pubmed-meshheading:19328622-Prostate-Specific Antigen, pubmed-meshheading:19328622-Prostatectomy, pubmed-meshheading:19328622-Prostatic Neoplasms, pubmed-meshheading:19328622-Risk Assessment, pubmed-meshheading:19328622-Survival Analysis, pubmed-meshheading:19328622-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
pubmed:affiliation
Urologische Klinik und Poliklinik, Klinikum der LMU-München, München, Germany. christoph.adam71@web.de
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II